• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Capillary Blood Collection Devices Companies

    ID: MRFR/MED/2869-CR
    114 Pages
    Rahul Gotadki
    December 2024

    Capillary blood collection devices are essential tools used in the collection of small blood samples for various diagnostic tests and procedures. These devices are commonly used in settings where venous blood collection is challenging or not feasible.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Capillary Blood Collection Devices Market Research Report - Global Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Capillary Blood Collection Devices Market

    Capillary Blood Collection Devices Key CompaniesDisclaimer: List of key companies in no particular orderLatest Capillary blood collection Companies Update



    • Oct 2023: Becton Dickinson and Casella Waste Systems released The latest findings of a recycling pilot program to handle discarded syringes and needles. The program resulted in the recycling and diversion of 40,000 lb of medical waste from disposal. The first significant attempt to evaluate the viability of recycling medical waste discovered in red sharps containers was the circular economy pilot conducted in the first half of 2023. Syringes and needles were among these containers' many medical supplies and equipment. All the plastics in the medical trash were recycled rather than disposed of after being gathered from various healthcare facilities. Additionally, the pilot evaluated the technical viability of advanced and mechanical recycling, demonstrating promising results regarding their ability to recycle used medical devices for use in other products.




    • Oct 2023: Recently, Novo Nordisk announced that the FLOW trial, which examines Ozempic (semaglutide) in diabetic individuals with chronic kidney disease, will end nearly a year before it was scheduled to because the treatment's success in treating kidney failure in this patient population could be demonstrated by the trial's interim results alone. Nevertheless, Novo Nordisk will remain unaware of the results until the trial's official conclusion. The company is already well-established in the markets for obesity and type 2 diabetes (T2D). As a result, Novo Nordisk's subcutaneous glucagon-like peptide-1 receptor agonist (GLP-1 RA) sales may benefit from the trial's encouraging outcomes in these and other potential therapy areas.


    List of Capillary blood collection Key companies in the market

    • F. Hoffmann-La Roche AG

    • Danaher Corporation

    • Abbott Laboratories

    • Novo Nordisk AS

    • Becton Dickinson and Company

    • Medtronic PLC

    • B. Braun Melsungen AG

    • Thermo Fisher Scientific Inc.

    • Terumo Corporation

    • Ypsomed Holding AG

    • HTL-STREFA SA

    • Sarstedt AG & Co

    • Owen Mumford Ltd

    • Greiner Bio-One

    • Improve Medical

    • Chengdu Rich Science Industry Co., Ltd.